Nucleic acid and chitosan mixed composition is used to relieve and improve joint pain disease.
It is an invention that relates to a composition for articular cavity injection comprising nucleic acid and chitosan. In the composition, the nucleic acid and chitosan are mixed to improve joint mobility and are believed to be effective in alleviating and improving joint pain disease.
The composition is prepared by a patented technology that does not cause sediment formation and layer separation, thus, is able to produce gel stability and biocompatibility which promotes the intra-articular injection. The patent has already been registered in
"PN (Polynucleotide) joint cavity injection with Conjuran® has established itself as a representative product that is driving our company's growth," said an official from
On the other hand,
Media Contact
Company
Contact Person:
Email: dykim1@pharmaresearch.co.kr
Phone: +82-31-8039-1462
Address:77-19, Gwajangdanji-ro
City: Gangneung-si
State: Gangwon-do
Country:
Website: http://pharmaresearch.co.kr/eng/
Source: www.abnewswire.com
.
(C) 2021 M2 COMMUNICATIONS, source